Should you buy BLRX stock?
Last updated:
Based on market data through , StockInvest.us rates BioLineRx Ltd. (BLRX) as a Sell Candidate with a technical score of -1.72 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Up 0.07%
- 3-month trend forecast Down 11.37%
- Easy Tracking In The Watchlist
BioLineRx Ltd. stock price ended at $2.71 on Monday, after gaining 0.0738%
(Market data through Aug 10, 2026)
The BioLineRx Ltd. stock price gained 0.0738% on the last trading day (Monday, 10th Aug 2026), rising from $2.71 to $2.71. During the last trading day the stock fluctuated 3.38% from a day low at $2.66 to a day high of $2.75. The price has fallen in 6 of the last 10 days and is down by -3.73% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 thousand more shares were traded than the day before. In total, 9 thousand shares were bought and sold for approximately $23.88 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.62 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -11.37% during the next 3 months and, with a 90% probability hold a price between $2.33 and $3.04 at the end of this 3-month period.
BLRX Signals & Forecast
There are mixed signals in the stock today. The BioLineRx Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.74 and $2.96. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Monday, August 03, 2026, and so far it has risen 1.95%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). BioLineRx Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for BioLineRx Ltd. stock
BioLineRx Ltd. finds support from accumulated volume at $2.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0900 between high and low, or 3.38%. For the last week, the stock has had daily average volatility of 5.61%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (BLRX) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect BioLineRx Ltd. to open at $2.71, and during the day (based on 14 day Average True Range), to move between $2.62 and $2.80, which gives a possible trading interval of +/-$0.178 (+/-6.80%) up or down from last closing price. If BioLineRx Ltd. takes out the full calculated possible swing range there will be an estimated 6.80% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.71 (0.07%) than the resistance at $3.01 (10.99%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
BioLineRx Ltd. will release earnings BMO on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.150. We will update the financials statements for BioLineRx Ltd., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.23% in the first trading day after earnings release.
Is BioLineRx Ltd. stock A Buy?
BioLineRx Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-1.720
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $2.71 ( 0.172%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
BLRX Performance
Trading levels for BLRX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.80 | 3.15% |
| R2 | 2.76 | 1.88% |
| R1 | 2.74 | 1.10% |
| Price | 2.71 | |
| S1 | 2.67 | -1.44% |
| S2 | 2.65 | -2.22% |
| S3 | 2.62 | -3.49% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.37 | 24.26% |
| R2 | 3.26 | 20.21% |
| R1 | 3.01 | 10.99% |
| Price | 2.71 | |
| S1 | 2.71 | -0.0737% |
| S2 | 2.70 | -0.442% |
| S3 | 2.63 | -3.02% |
FAQ
Click here for our free guide on how to buy BioLineRx Ltd. Stock.
Buy BLRX